← Back to Search

Behavioral Intervention

Care Navigation for Methamphetamine Addiction (BEATMeth Trial)

N/A

Recruiting

Led By Alia A Al-Tayyib, PhD

Research Sponsored by Denver Health and Hospital Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

BEATMeth Trial Summary

This trial aims to see if a system-level plan can help prevent stimulant drug overdoses. #prevention

Who is the study for?

This trial is for adults over 18 who've had a meth-related health issue at Denver Health and haven't received substance use treatment there in the last 90 days. It's not for those planning to enter substance treatment soon, unable to interview in English, impaired, or under involuntary psychiatric/substance treatment orders.Check my eligibility

What is being tested?

The study tests how well a new system-level strategy works to prevent overdoses related to stimulant use by providing care navigation services as an early intervention method.See study design

What are the potential side effects?

Since this trial involves care navigation rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological discomfort discussing their addiction.

BEATMeth Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

BEATMeth Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who entered treatment for methamphetamine use disorder

Secondary outcome measures

Number of participants retained in treatment at 30 days

Number of participants retained in treatment at 90 days

Number of participants who overdosed

BEATMeth Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Dedicated care navigator to address social support needs

Group II: Usual careActive Control1 Intervention

Standard of care.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,477,220 Total Patients Enrolled

Denver Health and Hospital AuthorityLead Sponsor

101 Previous Clinical Trials

400,215 Total Patients Enrolled

Alia A Al-Tayyib, PhDPrincipal InvestigatorDenver Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the size of the participant pool enrolled in this experiment?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial is still recruiting participants, the first posting being on April 11th 2023 and its most recent update occurring on September 11th of the same year. 182 individuals are needed at a single medical centre to participate in this study."

Answered by AI

Is there currently an opportunity to become involved in this examination?

"Confirmed. The trial, which was first posted on April 11th 2023, is presently recruiting as indicated by the clinicaltrials.gov portal. 182 participants are needed at a single medical centre for this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Beginning Early and Assertive Treatment for Methamphetamine Use Disorder

2023. "Beginning Early and Assertive Treatment for Methamphetamine Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06033365.